Headline
The latest stories from AHA Today.
The New Hampshire Hospital Association recently released a report highlighting the challenges New Hampshire hospitals and health systems face in dealing with Anthem, the state’s largest insurance provider, including nearly $300 million in unprocessed claims for services provided by New Hampshire…
On April 24 at the AHA Annual Membership Meeting in Washington, D.C., AHA will present its highest honor — the Distinguished Service Award — to Jim Skogsbergh, co-CEO of Advocate Health in Downers Grove, Ill., for his long career as a leader in health care transformation and innovation, patient…
Three Massachusetts health care leaders discuss a new state Code of Conduct for patients and visitors to reduce violence and assaults against health care workers.
The Department of Health and Human Services today announced a $1.1 billion public-private partnership to help maintain access to COVID-19 vaccines and treatment for uninsured individuals through pharmacies, health centers and state and local public health departments after the federal government no…
The House Energy and Commerce Health Subcommittee today held a legislative hearing on federal programs to strengthen the health care workforce and primary care.
Hospital and Healthsystem Association of Pennsylvania taps Nicole Stallings as new president and CEO
Nicole Stallings will be the next president and CEO of the Hospital and Healthsystem Association of Pennsylvania, it was announced.
On April 24 at the AHA Annual Membership Meeting in Washington, D.C., the AHA will present its 2023 Award of Honor to Speaker Emerita Nancy Pelosi for her efforts to advance health care. Pelosi was a central figure in development and passage of the Affordable Care Act of 2010.
The Healthcare Sector Coordinating Council and Department of Health and Human Services released a report benchmarking best practices and opportunities for improvement in hospital cyber resiliency.
About 84% of hospitals had posted a machine-readable file containing rate information by the end of first-quarter 2023, up from 65% the previous quarter, according to a report released by Turquoise Health.
The Food and Drug Administration authorized using a single dose of the Moderna or Pfizer bivalent COVID-19 vaccine for primary vaccination as well as for future doses. Under today’s amended emergency use authorizations, the monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer…